AJP - Heart Fuel your research with LabChart
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Heart Circ Physiol 291: H2192-H2198, 2006. First published June 9, 2006; doi:10.1152/ajpheart.01146.2005
0363-6135/06 $8.00
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
291/5/H2192    most recent
01146.2005v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (2)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sridhar, A.
Right arrow Articles by Carnes, C. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sridhar, A.
Right arrow Articles by Carnes, C. A.

Abnormal diastolic currents in ventricular myocytes from spontaneous hypertensive heart failure rats

Arun Sridhar,1,2,3 Spencer J. Dech,1,3 Veronique A. Lacombe,1,3 Terry S. Elton,1,3 Sylvia A. McCune,4 Ruth A. Altschuld,1,2,4 and Cynthia A. Carnes1,2,3

1Davis Heart and Lung Research Institute, 2Ohio State University Biophysics Program, 3College of Pharmacy; and 4Department of Molecular and Cellular Biochemistry, The Ohio State University, Columbus, Ohio

Submitted 31 October 2005 ; accepted in final form 25 May 2006


    ABSTRACT
 TOP
 ABSTRACT
 METHODS
 RESULTS
 DISCUSSION
 GRANTS
 REFERENCES
 
Hypertension is a common cause of heart failure, and ventricular arrhythmias are a major cause of death in heart failure. The spontaneous hypertension heart failure (SHHF) rat model was used to study altered ventricular electrophysiology in hypertension and heart failure. We hypothesized that a reduction in the inward rectifier K+ current (IK1) and expression of pacemaker current (If) would favor abnormal automaticity in the SHHF ventricle. SHHF ventricular myocytes were isolated at 2 and 8 mo of age and during end-stage heart failure (≥17 mo); myocytes from age-matched rats served as controls. Inward IK1 was significantly reduced at both 8 and ≥17 mo in SHHF rats compared with controls. There was a reduction in inward IK1 due to aging in the controls only at ≥17 mo. We found a significant increase in If at all ages in the SHHF rats, compared with young controls. In controls, there was an age-dependent increase in If. Action potential recordings in the SHHF rats demonstrated abnormal automaticity, which was abolished by the addition of an If blocker (10 µM zatebradine). Increased If during hypertension alone or combined increases in If with reduced IK1 during the progression to hypertensive heart failure contribute to a substrate for arrhythmogenesis.

aging; pacemaker current; inward rectifier potassium current; abnormal automaticity


HYPERTENSION CAN LEAD TO COMPENSATORY hypertrophy in cardiac muscle. Chronically, these compensatory mechanisms can become maladaptive, and cardiomyopathy and heart failure can result (22). Experimental animal studies in hypertrophy and heart failure have shown abnormalities in ion channel function, altered expression and function of proteins involved in excitation-contraction coupling, and an increased propensity for cardiac arrhythmias (16, 30, 32). Clinically, ventricular arrhythmias occur in 80% of heart failure patients (11). However, the mechanisms of arrhythmogenic electrophysiological remodeling during hypertension and hypertensive heart failure are not fully elucidated.

Spontaneous hypertensive heart failure (SHHF) rats develop hypertension at an early age. In contrast to spontaneously hypertensive rats (SHRs), the SHHF rats consistently develop reproducible, hypertensive heart failure in an age-dependent manner (26). Echocardiographic studies in the SHHF rat demonstrate left ventricular dysfunction (left ventricular ejection fraction <40%) at 17–18 mo of age (31). There is also evidence of progressive cardiac hypertrophy in the SHHF rats, evidenced as an increase in heart weights (36).

Hypertension and heart failure can increase the pacemaker current (If) in the ventricular myocardium (47). This can pathologically alter the diastolic phase of the action potential and enhance abnormal automaticity. In addition, aging has been shown to increase If density in both normal and hypertensive (SHR) rat ventricles (5).

Normally, the diastolic membrane potential is primarily regulated by the inward rectifier K+ current (IK1). IK1 is reduced in heart failure and, consequently, may contribute to increased excitability of the ventricle (30). We hypothesized that chronic hypertension and the resultant heart failure would lead to altered diastolic membrane currents, providing a substrate for abnormal excitability and automaticity. We measured IK1 and If in SHHF rats during the development of hypertension and heart failure in comparison to age-matched controls. Our observations suggest that changes in IK1 and If provide a mechanism for the initiation of ventricular arrhythmias during hypertension, heart failure, and aging.


    METHODS
 TOP
 ABSTRACT
 METHODS
 RESULTS
 DISCUSSION
 GRANTS
 REFERENCES
 
SHHF rats were obtained from the colony produced by S. McCune at the Ohio State University (25). Only phenotypically lean SHHF rats of either sex were used for this study. SHHF rats of either sex were studied at 2 and 8 mo of age and after the development of overt heart failure. As previously described, heart failure was identified between 16 and 22 mo of age and was defined as a left ventricular ejection fraction <40% by echocardiography, with signs of labored breathing, cyanosis, subcutaneous edema, piloerection, cold extremities (tails), and orthopnea (8, 26). Age-matched Wistar-Furth or Wistar rats (Harlan, Indianapolis, IN) of either sex were used as controls (8, 31).

Animals were deeply anesthetized with intraperitoneal injection of pentobarbital sodium, and the heart was rapidly removed. After the heart was flushed, it was weighed, and heart weight-to-body weight ratio was calculated. All animal procedures were approved by the Ohio State University Institutional Laboratory Animal Care and Use Committee.

Voltage-clamp recordings. Ventricular myocytes were isolated by using a previously described method (3). Myocytes were stored at room temperature under an oxygen hood until studied. Only cells with clear striations and sharp margins were studied. All data were acquired within 8 h of cell isolation to minimize potential time-dependent changes in the currents.

Cells were placed in a dish (Cell Microcontrols, Virginia Beach, VA) and superfused with test solutions; the bath temperature was maintained at 35°C with a temperature controller (Cell Microcontrols). Solutions were changed with a six-port gravity flow system (~1 ml/min). Data acquisition was performed with pClamp software (version 8, Axon Instruments, Union City, CA) and an Axopatch 200A patch-clamp amplifier (Axon Instruments).

The amphotericin B-perforated, whole cell, patch-clamp technique was used for all recordings to minimize alterations in the intracellular milieu. Patch pipettes (2–5 M{Omega}) were used, and after seal formation, changes in the capacitative response to a –10-mV step were used to monitor perforation of the patch by amphotericin B. Series resistance compensation was applied (40–60%) to minimize voltage errors. Only cells with low access resistance (<20 M{Omega}) that was stable (<20% change in series resistance) were included in the data analysis.

The bath solution contained (in mM) 134 NaCl, 1 MgCl2, 5 KCl, 5 HEPES, 1 CaCl2, and 5 D-glucose; pH was adjusted to 7.40 with NaOH. Nifedipine (2 µM) was added to the bath solution to block L-type calcium current. The pipette solution contained (in mM) 130 KCl, 5 MgCl2, 5 HEPES, and 5 EGTA; pH was adjusted to 7.2 with KOH.

A holding potential of –40 mV was used for all voltage-clamp experiments to inactivate sodium current. A series of 100-ms test potentials from –140 to +40 mV, with a 20-mV increment, were used to elicit IK1. The current was measured at the end of each 100-ms test potential. IK1 was defined as barium-sensitive current and was measured as the difference in current between that in the control solution and that in the bath solution with 2 mM BaCl2. If was measured after the addition of BaCl2 to the bath solution. If was elicited by using 1-s voltage steps from –130 to –50 mV applied at 5-s intervals. If was measured as the difference between the instantaneous inward current and that at the end of each voltage step.

Action potentials. In separate experiments, we used current-clamp recordings to evaluate resting potential and abnormal automaticity. For these recordings, the bath solution contained (in mM) 134 NaCl, 1 MgCl2, 5 KCl, 5 HEPES, 1.8 CaCl2, and 5 D-glucose; pH was adjusted to 7.40 with NaOH. Cells were stimulated at 0.2, 0.5, 1, and/or 2 Hz. The proportion of myocytes exhibiting abnormal automaticity was calculated. Zatebradine (10 µM) was used as an If blocker (12, 39).

Reagents. Zatebradine was supplied by Boehringer Ingleheim Pharma. All other reagents were purchased from Sigma Chemical (St. Louis, MO).

Data analysis. Cardiac hypertrophy was assessed by the heart weight-to-body weight ratio [heart wt (in mg)/body wt (in g)] (37). The measured currents were expressed as current density (in pA/pF) after normalization for cell capacitance. IK1 inward conductance (in mS/cm2) was determined by calculating the slope of the linear portion of the current density-voltage relationship from –140 mV to –100 mV (3). Peak outward IK1 density was measured at –60 mV (I–60). The IK1 rectification ratio was calculated as {[(I–100) – (I–60)]/I–100} x 100 (2, 24).

In pilot experiments, we constructed a threshold (>–0.60 pA/pF) for identification of If by identifying a value that included 95% of the end-stage heart failure myocytes while excluding 90% of the 2-mo-old control myocytes. To assess the physiological relevance of If, only cells classified as having significant If were included in the analysis of current differences at –90 mV.

If current density (in pA) was normalized to the cell capacitance (in pF) and expressed as pA/pF. All data were included for the current-voltage and current density-voltage relationship analyses.

Initial statistical analysis revealed no sex-dependent statistical differences; male and female data were pooled for further analyses. Two-way ANOVA with post hoc Student-Newman-Keuls test was used to test for differences between groups. One-way ANOVA was used to test for age-dependent cardiac hypertrophy in the SHHF rats. Differences in the proportion of cells demonstrating If (as defined above) were assessed by using the Pearson {chi}2-square test. Data are presented as means ± SE. Statistical significance was defined as P < 0.05. Statistical analysis was performed using SAS for Windows (version 8.0.1; SAS Systems, Cary, NC).


    RESULTS
 TOP
 ABSTRACT
 METHODS
 RESULTS
 DISCUSSION
 GRANTS
 REFERENCES
 
The heart weight-to-body weight ratio was increased in the SHHF rats compared with controls at both 2 mo (7.2 ± 0.9 vs. 4.3 ± 0.2 in SHHF rats and controls, respectively, P < 0.05) and ≥17 mo (10.6 ± 1.6 vs. 3.2 ± 0.2 in SHHF rats and controls, respectively, P < 0.02). In controls, significant myocyte hypertrophy only occurred in the oldest group (Fig. 1).


Figure 1
View larger version (13K):
[in this window]
[in a new window]
 
Fig. 1. Cell capacitance as a function of rat strain and age. There is an increase in myocyte size in Wistar-Furth (WF) controls. Myocyte size is larger in spontaneous hypertensive heart failure (SHHF) rats than in controls at 8 and ≥17 mo of age. *P < 0.05 compared with 2-mo-old WF rats; {dagger}P < 0.05 compared with 8-mo-old WF rats; {ddagger}P < 0.05 compared with 2-mo-old SHHF rats; §P < 0.05 compared with ≥17-mo-old WF rats.

 
Inward rectifier IK1. Representative barium-sensitive current tracings and mean data from SHHF and control myocytes are shown in Fig. 2. In contrast to controls, in SHHF myocytes, there was a decrement in inward IK1 conductance at 8 mo, which was decreased further after the onset of heart failure (P < 0.05). Notably, even in control myocytes, there was a reduction in inward IK1 conductance at an advanced age; however, inward IK1 conductance in controls was still substantially larger compared with the age-matched SHHF rats (P < 0.05).


Figure 2
View larger version (20K):
[in this window]
[in a new window]
 
Fig. 2. K+ current (IK1) is altered by age in controls and by progression to heart failure in SHHF rats. A: barium-sensitive current density recordings from 2-mo-old (left) and 17-mo-old (right) WF rats. B: representative barium-sensitive current density recorded from 2-mo-old (left) and >17-mo-old (right) SHHF myocytes. In A and B, arrows indicate zero current. C: current density-voltage relationships of WF and SHHF myocytes. ({square}, 2-mo-old WF rats; {circ}, 8-mo-old WF rats; {triangleup}, 17-mo-old WF rats; {blacksquare}, 2-mo-old SHHF rats; bullet, 8-mo-old SHHF rats; {blacktriangleup}, >17-mo-old SHHF rats). D: normalized inward IK1 conductance for WF (open bars) and SHHF (solid bars) rats at different ages. Numbers on each bar indicate total cells in each group. E: peak outward current at –60 mV as a function of strain at different ages. F: rectification ratio for WF and SHHF rats (*age-dependent change from 2-mo-old WF rats; {dagger}different from 8-mo-old WF rats; {ddagger}age-dependent change from 2-mo-old SHHF rats; §different from 8-mo-old SHHF rats; #different from 17-mo-old WF rats; P < 0.05).

 
Analysis of peak outward IK1 showed no age-dependent change in the controls. The SHHF rats showed a substantial reduction in peak outward IK1, but only during heart failure. The rectification ratio was decreased in an age-dependent manner in controls, consistent with reduced rectification of the current as a function of "normal" aging. In the SHHF rats, there was a significantly larger reduction in the rectification ratio at the oldest age compared with age-matched controls, consistent with a further decrement in current rectification with heart failure. In summary, normal aging, hypertension and hypertrophy, and heart failure all appeared to reduce the IK1 rectification ratio.

If. Figure 3 depicts barium-insensitive current recordings (A and B) and summary data for ventricular If in Wistar-Furth and SHHF rats in all myocytes tested (C and D). There was an age-dependent increase in If in Wistar-Furth rats. In SHHF rats, the If was larger at all ages compared with 2-mo-old controls. There were no age- or heart failure-dependent increases in If density in the SHHF groups. When only cells expressing significant If (as defined in METHODS) were analyzed (Fig. 3, E and F), there were significantly more myocytes expressing If in the SHHF groups at both 2 and 8 mo of age. However, at ≥17 mo of age, there was no difference between control and SHHF rats in the proportion of myocytes expressing If. The amplitude of If increases as a function of myocyte size (Fig. 3F, P < 0.035).


Figure 3
View larger version (23K):
[in this window]
[in a new window]
 
Fig. 3. Pacemaker current (If) is altered by age in controls and by hypertension and heart failure in SHHF rats. A: barium-insensitive current density recordings from 2-mo-old WF myocyte (left) and 17-mo-old WF rat (right). B: barium-insensitive current density recorded from 2-mo-old SHHF rats (left) and end-stage SHHF rats (right). Dashed lines in A and B indicate zero current. C and D: current-voltage curves for WF and SHHF rats, respectively, at different ages ({square}, 2-mo-old WF rats; {circ}, 8-mo-old WF rats; {triangleup}, ≥17-mo-old WF rats; {blacksquare}, 2-mo-old SHHF rats; bullet, 8-mo-old SHHF rats; {blacktriangleup}, ≥17-mo-old SHHF rats). *P < 0.05 for current density-voltage relationship compared with that in 2-mo-old WF controls. E: percentage of myocytes in C and D expressing significant If in each group. *P < 0.05 compared with age-matched controls. F: relationship between cell size and If amplitude in control ({square}) and SHHF ({blacksquare}) myocytes. Current amplitude increases as cellular hypertrophy develops (r2 = 0.74 and P < 0.035).

 
Physiological impact of altered diastolic currents: abnormal automaticity. To evaluate the role of If at physiological resting membrane potentials, we conducted an additional analysis at a test potential of –90 mV. There was a significant difference between groups at 2 mo of age (–0.06 ± 0.04 vs. –0.27 ± 0.36 pA/pF in control and SHHF rats, respectively). At 8 and ≥17 mo of age, there was no significant difference between groups in the If at –90 mV.

We recorded action potentials from 2-mo-old (10 cells) and 8-mo-old (3 cells) SHHF rats. Action potentials were recorded in 11 myocytes from 2- to 6-mo-old Wistar rats; no age-dependent differences in action potential characteristics were found in the Wistar myocytes, and these data were pooled (resting membrane potential of –81.2 ± 2.6 and –82.4 ± 1.7 mV at 2 and 6 mo, respectively). There was no difference between 2-mo-old SHHF myocytes and control myocytes in the resting membrane potential. The resting membrane potential was reduced in the 8-mo-old SHHF myocytes compared with Wistar controls (P < 0.05). There was an age-dependent reduction in resting membrane potential in myocytes from the SHHF rats, because the 8-mo-old SHHF myocytes (where IK1 was reduced) were depolarized compared with 2-mo-old SHHF myocytes (–72.2 ± 1.8 vs. –80.6 ± 1.2 mV, respectively; P < 0.05).

In control myocytes, we did not observe any evidence of abnormal automaticity (0 of 11). In contrast, in the 2-mo-old SHHF myocytes, we observed abnormal automaticity in three of five myocytes at 0.2 Hz. At a faster stimulation rate of 0.5 Hz, none of the myocytes (zero of 8) from the 2-mo-old SHHF rats exhibited abnormal automaticity; in contrast, two out of three myocytes from the 8-mo-old SHHF rats exhibited abnormal automaticity at 0.5 Hz. Abnormal automaticity was abolished by zatebradine (If channel blocker) and reappeared after washout of zatebradine (Fig. 4). At stimulation rates of 1 and 2 Hz, no abnormal automaticity (0/13) was evident in the SHHF myocytes.


Figure 4
View larger version (14K):
[in this window]
[in a new window]
 
Fig. 4. Abnormal automaticity in myocytes from SHHF rats is abolished by If blocker (zatebradine). Representative action potential recordings in 2-mo-old SHHF myocyte at 0.2 Hz (A), after 3 min of superfusion with zatebradine (B), and after 5 min of washout of zatebradine (C) are shown. Insets, A and C: diastolic depolarization reaching threshold for abnormal automaticity (marked by asterisk).

 

    DISCUSSION
 TOP
 ABSTRACT
 METHODS
 RESULTS
 DISCUSSION
 GRANTS
 REFERENCES
 
There is an increased prevalence of ventricular arrhythmias (premature ventricular depolarizations and nonsustained ventricular tachycardia) observed during aging in healthy humans (10, 18, 21). The frequency and complexity of ventricular arrhythmias are increased in hypertensive patients, even in the absence of left ventricular hypertrophy (9). The presence of left ventricular hypertrophy in hypertensive patients results in increased complexity and frequency of ventricular arrhythmias, including sudden cardiac death (1, 34, 35). Interpretation of studies evaluating arrhythmias in patients with hypertensive left ventricular hypertrophy is potentially confounded by the use of pharmacotherapy with the potential to cause electrolyte imbalances, and thus, result in increased arrhythmia risk. During heart failure, ventricular arrhythmias occur in ~80% of patients (11), and many with heart failure die of sudden cardiac death. We used the SHHF rat model and age-matched controls to evaluate the ventricular diastolic membrane currents, IK1 and If, and found differential regulation of these currents by hypertension, heart failure, and aging.

SHHF rats are a reliable model for human hypertension and heart failure. Systolic blood pressures are consistently elevated in the SHHF rats but are decreased after the progression to significant heart failure (which typically occurs in phenotypically lean SHHF rats at 15–30 mo of age) (15, 26). Myocyte size is increased as early as 2 mo of age in SHHF rats, and progressive myocyte and cardiac hypertrophy have been reported through 12 mo of age in the SHHF rats (28). During heart failure, the SHHF rats have intracardiac thrombi, myocyte hypertrophy, and increased cardiac interstitial fibrosis (17).

Wistar and Wistar-Furth rats have been used as a suitable control for SHHF rats (8). Wistar-Furth rats have normal blood pressures during early to middle adult ages (14), although, recently, the systolic blood pressure in aged Wistar-Furth rats (21 mo old) was reported to be elevated, ~160 mmHg (38). Thus it is possible that hypertension may have contributed to the increased myocyte capacitance and increased If in the aged controls.

We observed an age-dependent decrement in IK1 in the control group. This is in contrast to previous reports where no change in IK1 was reported when comparing ventricular myocytes from 3- and 9-mo-old (20) or young and senescent (24- to 25-mo-old) Wistar rats (40). Although we did observe a reduction in the aged control rats, there was a significantly greater reduction in IK1 with age and disease progression in SHHF rats. When compared with SHHF rats, the age-matched Wistar-Furth rats expressed a statistically decreased inward conductance only in the ≥17-mo age group. To our knowledge, this decrease in inward IK1 during aging has not been previously reported and could contribute to a depolarized diastolic membrane potential.

The peak outward IK1 was significantly altered only in end-stage SHHF rats, consistent with a heart failure-induced response. This reduction would be expected to result in a prolongation of terminal repolarization and has been previously described in other heart failure models (16, 32). We observed a significant reduction in the IK1 rectification ratio with age in both controls and SHHF rats. The rectification ratio decrease was more pronounced in SHHF rats than in Wistar-Furth rats. Rectification of IK1 is modulated by testosterone, intracellular magnesium, and intracellular polyamines; (2, 23, 27) alterations in these regulators have been reported during aging, hypertension and heart failure, (13, 19, 29, 33) and may be the basis of this observation.

In normal human and rat hearts, there is a low level of ventricular If, and the proportion of cells with significant If is less in controls, when compared with myocytes from failing hearts (5, 7). Ventricular If is increased in both amplitude and prevalence with both normal aging and hypertension in rats (4, 5). The age-dependent increase we observed in the proportion of myocytes expressing If in controls is similar to that reported in normal Wistar-Kyoto rats (5). Notably, the age dependence of the proportion of myocytes we observed with If in the SHHF rats differs from that previously reported in SHRs, where the occurrence of If in young SHRs did not differ from that in young controls (5). The reason for this difference is unclear; it is interesting to note that, whereas both SHRs and SHHF rats are hypertensive at a young age, only SHHF rats consistently progress to develop heart failure at an early age.

Similar to the observed increases in If in both control and SHHF rats, ventricular If is increased in human myocytes as a result of normal aging, hypertension, and heart failure (6, 7). We found that the amplitude of If was positively correlated with cell size, and this suggests that hypertrophy, and not heart failure per se, increases If, consistent with a previous report in hypertensive rats (4). This relationship explains why we did not observe a further increase in current density with progressive heart failure in the SHHF rats, as there was no further increase in myocyte capacitance (Fig. 1).

The early occurrence of If in the SHHF rats is consistent with the known response to hypertension (5). Thus our data suggest that hypertension can mediate increased If even at an early age in the SHHF rat. Progression from hypertension to hypertensive heart failure increases If amplitude, but not current density, because amplitude is tightly correlated with myocyte size. This differs from a previous report by Cerbai et al. (5) in SHRs where cell size did not correlate with If amplitude, although they did observe a significant correlation in controls.

The physiological relevance of the If expression in the SHHF rats can be evaluated by comparing the current at –90 mV (to approximate a normal resting potential). This reveals a significant increase in current amplitude as a function of age in both control and SHHF rats, although the current was always larger in the SHHF rats.

If is a time-dependent current, so we used variable action potential stimulation rates to assess the physiological impact of If. Our data indicate that increased If alone (as observed in the 2-mo-old SHHF rats) is sufficient to result in abnormal automaticity, only at very low stimulation rates (0.2 Hz). On the basis of the data from both 2- and 8-mo-old SHHF myocytes, both an increase in If and a reduction in inward IK1 are necessary for abnormal automaticity to occur at a faster stimulation rate (0.5 vs. 0.2 Hz). Our data suggest that altered excitability through a combination of decreases in IK1 and increases in If could precipitate arrhythmias during aging, hypertension, and heart failure.

Limitations. We did not directly measure blood pressure in our cohort of animals. However, the SHHF rats have reproducible blood pressures at the time points used in this study, which we obtained from the literature. The SHHF rats in this study were phenotypically lean, a mixture of animals heterozygous for or lacking the cp (corpulent) gene. This factor, and the use of both males and females, resulted in a more variable onset of heart failure than would be seen in genotypically lean rats of one sex. To control for this variable, we used echocardiography to define the presence of heart failure, using previously established criteria (8, 28).

In conclusion, by using young adult and aged SHHF rats and control rats, we found that aging, hypertension, and heart failure have variable effects on diastolic membrane currents. Reductions in IK1 and increases in If are both arrhythmogenic, and the magnitude of these changes is affected by age, hypertension, and heart failure. The finding of reduced IK1 in aged controls is interesting, as there are increased ventricular arrhythmias during normal aging in humans (10, 18). Our results indicate that the underlying cause of arrhythmias may vary during the progression from hypertension to heart failure. IK1 is functionally regulated by testosterone, intracellular magnesium, and intracellular polyamines, whereas If is regulated by the autonomic nervous system. This suggests that therapeutic interventions targeting each of these ionic currents may be required to minimize ventricular arrhythmias during the progression of hypertensive heart failure.


    GRANTS
 TOP
 ABSTRACT
 METHODS
 RESULTS
 DISCUSSION
 GRANTS
 REFERENCES
 
This project was supported in part by the American Heart Association, National Center (to C. A. Carnes).


    ACKNOWLEDGMENTS
 
Present addresses: S. J. Dech, Merck & Co., PO Box 4, 770 Sumneytown Pike, WP 81–220, West Point, PA 19486; S. A. McCune, Myogen, Inc., Westminster, CO 80021, and Department of Integrative Physiology, University of Colorado, Boulder, CO 80309.


    FOOTNOTES
 

Address for reprint requests and other correspondence: C. A. Carnes, Ohio State Univ., College of Pharmacy, 500 W. 12th Ave., Columbus, OH 43210 (e-mail: carnes.4{at}osu.edu)

The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.


    REFERENCES
 TOP
 ABSTRACT
 METHODS
 RESULTS
 DISCUSSION
 GRANTS
 REFERENCES
 

  1. Bikkina M, Larson MG, and Levy D. Asymptomatic ventricular arrhythmias and mortality risk in subjects with left ventricular hypertrophy. J Am Coll Cardiol 22: 1111–1116, 1993.[Abstract]
  2. Carnes CA and Dech SJ. Effects of dihydrotestosterone on cardiac inward rectifier K+ current. Int J Androl 25: 210–214, 2002.[CrossRef][ISI][Medline]
  3. Carnes CA, Muir WW III, and Van Wagoner DR. Effect of intravenous anesthetics on inward rectifier potassium current in rat and human ventricular myocytes. Anesthesiology 87: 327–334, 1997.[CrossRef][ISI][Medline]
  4. Cerbai E, Barbieri M, and Mugelli A. Characterization of the hyperpolarization-activated current, If, in ventricular myocytes isolated from hypertensive rats. J Physiol 481: 585–591, 1994.[Abstract/Free Full Text]
  5. Cerbai E, Barbieri M, and Mugelli A. Occurrence and properties of the hyperpolarization-activated current If in ventricular myocytes from normotensive and hypertensive rats during aging. Circulation 94: 1674–1681, 1996.[Abstract/Free Full Text]
  6. Cerbai E, Pino R, Porciatti F, Sani G, Toscano M, Maccherini M, Giunti G, and Mugelli A. Characterization of the hyperpolarization-activated current, If, in ventricular myocytes from human failing heart. Circulation 95: 568–571, 1997.[Abstract/Free Full Text]
  7. Cerbai E, Sartiani L, DePaoli P, Pino R, Maccherini M, Bizzarri F, DiCiolla F, Davoli G, Sani G, and Mugelli A. The properties of the pacemaker current If in human ventricular myocytes are modulated by cardiac disease. J Mol Cell Cardiol 33: 441–448, 2001.[CrossRef][ISI][Medline]
  8. Dumitrescu C, Narayan P, Efimov IR, Cheng Y, Radin MJ, McCune SA, and Altschuld RA. Mechanical alternans and restitution in failing SHHF rat left ventricles. Am J Physiol Heart Circ Physiol 282: H1320–H1326, 2002.[Abstract/Free Full Text]
  9. Fariello R, Crippa M, Damiani G, Notaristefano I, Costa R, Boni E, Corda L, Chiari E, and Zaninelli A. Ventricular arrhythmias in normotensive subjects and in mild hypertensive patients. Angiology 49: 99–103, 1998.[ISI][Medline]
  10. Fleg JL and Kennedy HL. Long-term prognostic significance of ambulatory electrocardiographic findings in apparently healthy subjects greater than or equal to 60 years of age. Am J Cardiol 70: 748–751, 1992.[CrossRef][ISI][Medline]
  11. Francis GS. Development of arrhythmias in the patient with congestive heart failure: pathophysiology, prevalence and prognosis. Am J Cardiol 57: 3B–7B, 1986.[CrossRef][Medline]
  12. Gill CH, Randall A, Bates SA, Hill K, Owen D, Larkman PM, Cairns W, Yusaf SP, Murdock PR, Strijbos PJ, Powell AJ, Benham CD, and Davies CH. Characterization of the human HCN1 channel and its inhibition by capsazepine. Br J Pharmacol 143: 411–421, 2004.[CrossRef][ISI][Medline]
  13. Haigney MC, Wei S, Kaab S, Griffiths E, Berger R, Tunin R, Kass D, Fisher WG, Silver B, and Silverman H. Loss of cardiac magnesium in experimental heart failure prolongs and destabilizes repolarization in dogs. J Am Coll Cardiol 31: 701–706, 1998.[Abstract/Free Full Text]
  14. Hamlin RL. Measurements of left and right ventricular pressures and their derivatives by transcutaneous puncture in rats. Am J Vet Res 53: 34–35, 1992.[ISI][Medline]
  15. Heyen JR, Blasi ER, Nikula K, Rocha R, Daust HA, Frierdich G, Van Vleet JF, De Ciechi P, McMahon EG, and Rudolph AE. Structural, functional, and molecular characterization of the SHHF model of heart failure. Am J Physiol Heart Circ Physiol 283: H1775–H1784, 2002.[Abstract/Free Full Text]
  16. Kaab S, Nuss HB, Chiamvimonvat N, O'Rourke B, Pak PH, Kass DA, Marban E, and Tomaselli GF. Ionic mechanism of action potential prolongation in ventricular myocytes from dogs with pacing-induced heart failure. Circ Res 78: 262–273, 1996.[Abstract/Free Full Text]
  17. Kambara A, Holycross BJ, Wung P, Schanbacher B, Ghosh S, McCune SA, Bauer JA, and Kwiatkowski P. Combined effects of low-dose oral spironolactone and captopril therapy in a rat model of spontaneous hypertension and heart failure. J Cardiovasc Pharmacol 41: 830–837, 2003.[CrossRef][ISI][Medline]
  18. Komsuoglu B, Duman E, Komsuoglu SS, and Gorcin B. Prevalence of ventricular premature complexes in healthy and untreated hypertensive elderly people. Angiology 44: 447–453, 1993.[ISI][Medline]
  19. Kontoleon PE, Anastasiou-Nana MI, Papapetrou PD, Alexopoulos G, Ktenas V, Rapti AC, Tsagalou EP, and Nanas JN. Hormonal profile in patients with congestive heart failure. Int J Cardiol 87: 179–183, 2003.[CrossRef][ISI][Medline]
  20. Leblanc N, Chartier D, Gosselin H, and Rouleau JL. Age and gender differences in excitation-contraction coupling of the rat ventricle. J Physiol 511: 533–548, 1998.[Abstract/Free Full Text]
  21. Levy D, Anderson KM, Plehn J, Savage DD, Christiansen JC, and Castelli WP. Echocardiographically determined left ventricular structural and functional correlates of complex or frequent ventricular arrhythmias on one-h ambulatory electrocardiographic monitoring. Am J Cardiol 59: 836–840, 1987.[CrossRef][ISI][Medline]
  22. Levy D, Larson MG, Vasan RS, Kannel WB, and Ho KK. The progression from hypertension to congestive heart failure. JAMA 275: 1557–1562, 1996.[Abstract]
  23. Lopatin AN, Makhina EN, and Nichols CG. The mechanism of inward rectification of potassium channels: "long-pore plugging" by cytoplasmic polyamines. J Gen Physiol 106: 923–955, 1995.[Abstract/Free Full Text]
  24. Lopatin AN, Shantz LM, Mackintosh CA, Nichols CG, and Pegg AE. Modulation of potassium channels in the hearts of transgenic and mutant mice with altered polyamine biosynthesis. J Mol Cell Cardiol 32: 2007–2024, 2000.[CrossRef][ISI][Medline]
  25. McCune SA, Baker PB, and Stills HF. SHHF/Mcc-cp rat: model of obesity, non-insulin-dependent diabetes and congestive heart failure. ILAR News 32: 23–37, 1990.
  26. McCune SA, Park S, Radin MJ, and Jurin RR. SHHF/Mcc-facp rat model: a genetic model of congestive heart failure. In: Mechanisms of Heart Failure, edited by Singal PK, Dixon IMC, Beamish RE, and Dhalla NS. Norwell, MA: Kluwer Acad., 1995, p. 91–106.
  27. Nichols CG, Makhina EN, Pearson WL, Sha Q, and Lopatin AN. Inward rectification and implications for cardiac excitability. Circ Res 78: 1–7, 1996.[Abstract/Free Full Text]
  28. Onodera T, Tamura T, Said S, McCune SA, and Gerdes AM. Maladaptive remodeling of cardiac myocyte shape begins long before failure in hypertension. Hypertension 32: 753–757, 1998.[Abstract/Free Full Text]
  29. Ottenweller JE, Tapp WN, Creighton D, and Natelson BH. Aging, stress, and chronic disease interact to suppress plasma testosterone in Syrian hamsters. J Gerontol 43: M175–M180, 1988.[ISI][Medline]
  30. Pogwizd SM, Schlotthauer K, Li L, Yuan W, and Bers DM. Arrhythmogenesis and contractile dysfunction in heart failure: roles of sodium-calcium exchange, inward rectifier potassium current, and residual beta-adrenergic responsiveness. Circ Res 88: 1159–1167, 2001.[Abstract/Free Full Text]
  31. Reffelmann T and Kloner RA. Transthoracic echocardiography in rats. Evalution of commonly used indices of left ventricular dimensions, contractile performance, and hypertrophy in a genetic model of hypertrophic heart failure (SHHF-Mcc-facp-rats) in comparison with Wistar rats during aging. Basic Res Cardiol 98: 275–284, 2003.[CrossRef][ISI][Medline]
  32. Rose J, Armoundas AA, Tian Y, Disilvestre D, Burysek M, Halperin V, O'Rourke B, Kass DA, Marban E, and Tomaselli GF. Molecular correlates of altered expression of potassium currents in failing rabbit myocardium. Am J Physiol Heart Circ Physiol 288: H2077–H2087, 2005.[Abstract/Free Full Text]
  33. Ruskoaho H and Raunio H. Altered cardiac polyamine biosynthesis in spontaneously hypertensive rats. Am J Physiol Heart Circ Physiol 253: H262–H269, 1987.[Abstract/Free Full Text]
  34. Saadeh AM and Jones JV. Predictors of sudden cardiac death in never previously treated patients with essential hypertension: long-term follow-up. J Hum Hypertens 15: 677–680, 2001.[CrossRef][ISI][Medline]
  35. Siegel D, Cheitlin MD, Black DM, Seeley D, Hearst N, and Hulley SB. Risk of ventricular arrhythmias in hypertensive men with left ventricular hypertrophy. Am J Cardiol 65: 742–747, 1990.[CrossRef][ISI][Medline]
  36. Tamura T, Onodera T, Said S, and Gerdes AM. Correlation of myocyte lengthening to chamber dilation in the spontaneously hypertensive heart failure (SHHF) rat. J Mol Cell Cardiol 30: 2175–2181, 1998.[CrossRef][ISI][Medline]
  37. Tamura T, Said S, Harris J, Lu W, and Gerdes AM. Reverse remodeling of cardiac myocyte hypertrophy in hypertension and failure by targeting of the renin-angiotensin system. Circulation 102: 253–259, 2000.[Abstract/Free Full Text]
  38. Thomas TA, Kuzman JA, Anderson BE, Andersen SM, Schlenker EH, Holder MS, and Gerdes AM. Thyroid hormones induce unique and potentially beneficial changes in cardiac myocyte shape in hypertensive rats near heart failure. Am J Physiol Heart Circ Physiol 288: H2118–H2122, 2005.[Abstract/Free Full Text]
  39. Van Bogaert PP and Pittoors F. Use-dependent blockade of cardiac pacemaker current (If) by cilobradine and zatebradine. Eur J Pharmacol 478: 161–171, 2003.[CrossRef][ISI][Medline]
  40. Walker KE, Lakatta EG, and Houser SR. Age associated changes in membrane currents in rat ventricular myocytes. Cardiovasc Res 27: 1968–1977, 1993.[Abstract/Free Full Text]



This article has been cited by other articles:


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
V. A. Lacombe, S. Viatchenko-Karpinski, D. Terentyev, A. Sridhar, S. Emani, J. D. Bonagura, D. S. Feldman, S. Gyorke, and C. A. Carnes
Mechanisms of impaired calcium handling underlying subclinical diastolic dysfunction in diabetes
Am J Physiol Regulatory Integrative Comp Physiol, November 1, 2007; 293(5): R1787 - R1797.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
291/5/H2192    most recent
01146.2005v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (2)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sridhar, A.
Right arrow Articles by Carnes, C. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sridhar, A.
Right arrow Articles by Carnes, C. A.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2006 by the American Physiological Society.